Conditional Licensing of Veterinary Biologicals in the United States: a Major Manufacturer's Perspective

摘要

Veterinary biologicals are important tools. They have been used for many years to prevent or to reduce the impact of many of the most deadly and costly diseases of animals. In the United States, as in most countries, veterinary vaccines are very heavily regulated. U.S. manufacturers are required to prepare the products under strict government supervision, mandated under the Virus Serum Toxin Act (VSTA) of 1913, as amended in 1985. In passing the VSTA in 1913, Congress assigned to the United States Department of Agriculture (USDA) the authority to ensure veterinary biologicals are not worthless, harmful, dangerous or contaminated. Enforcement of the VSTA remains the responsibility of the USDA Animal and Plant Health Inspection Service (APHIS) Centerfor Veterinary Biologicals (CVB).